Renaissance Technologies
RCEL icon

Renaissance Technologies’s Avita Medical RCEL Stock Holding History

Renaissance Technologies’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-23,600
Closed -$378K – 3881
2024
Q1 		$378K Sell
23,600
-13,200
-36% -$214K ﹤0.01% 2985
2023
Q4 		$505K Sell
36,800
-34,400
-48% -$394K ﹤0.01% 2772
2023
Q3 		$1.04M Sell
71,200
-28,800
-29% -$487K ﹤0.01% 2267
2023
Q2 		$1.7M Sell
100,000
-112,336
-53% -$1.65M ﹤0.01% 2099
2023
Q1 		$2.97M Sell
212,336
-3,976
-2% -$42.3K ﹤0.01% 1786
2022
Q4 		$1.43M Sell
216,312
-22,268
-9% -$133K ﹤0.01% 2293
2022
Q3 		$1.26M Sell
238,580
-88,700
-27% -$548K ﹤0.01% 2361
2022
Q2 		$1.55M Buy
327,280
+112,000
+52% +$692K ﹤0.01% 2379
2022
Q1 		$1.83M Buy
+215,280
New +$1.98M ﹤0.01% 2293
2021
Q1 		– Sell
-164,980
Closed -$3.06M – 3631
2020
Q4 		$3.06M Buy
164,980
+88,808
+117% +$1.95M ﹤0.01% 1879
2020
Q3 		$1.92M Sell
76,172
-14,928
-16% -$372K ﹤0.01% 2159
2020
Q2 		$2.78M Buy
91,100
+67,220
+281% +$2.06M ﹤0.01% 1986
2020
Q1 		$740K Buy
+23,880
New +$989K ﹤0.01% 2573

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies's RCEL Position: Q2 2024 in Review

Renaissance Technologies sold out of Avita Medical (RCEL) in Q2 2024, closing a stake of 23,600 shares — an estimated $378K sold.

Renaissance Technologies first reported a position in RCEL in Q1 2020 and held it in 13 quarters. The position peaked at $3.06M in Q4 2020. 68 funds tracked by Wall St. Rank hold RCEL as of Q2 2024.

  • Renaissance Technologies reported no remaining Avita Medical position as of Q2 2024 after selling out during the quarter.
  • Renaissance Technologies sold 23,600 Avita Medical shares in Q2 2024, an estimated $378K.
  • Renaissance Technologies first reported a position in Avita Medical in Q1 2020 and held it in 13 quarters.
  • Renaissance Technologies's Avita Medical position peaked at $3.06M in Q4 2020.
  • 68 funds tracked by Wall St. Rank held Avita Medical as of Q2 2024.

Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.